Outcome and Prognostic Factors in Stage III Favorable-Histology Wilms Tumor: A Report From the Children's Oncology Group Study AREN0532.

Fernandez, Conrad V

Outcome and Prognostic Factors in Stage III Favorable-Histology Wilms Tumor: A Report From the Children's Oncology Group Study AREN0532. [electronic resource] - Journal of clinical oncology : official journal of the American Society of Clinical Oncology 01 2018 - 254-261 p. digital

Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't

1527-7755

10.1200/JCO.2017.73.7999 doi


Adolescent
Antineoplastic Combined Chemotherapy Protocols--adverse effects
Biomarkers, Tumor--genetics
Chemoradiotherapy, Adjuvant--adverse effects
Child
Child, Preschool
Chromosomes, Human, Pair 1
Chromosomes, Human, Pair 16
Dactinomycin--administration & dosage
Doxorubicin--administration & dosage
Female
Genetic Predisposition to Disease
Humans
Infant
Kidney Neoplasms--genetics
Loss of Heterozygosity
Lymph Nodes--pathology
Lymphatic Metastasis
Male
Neoplasm Staging
Nephrectomy
Phenotype
Progression-Free Survival
Prospective Studies
Radiation Dosage
Risk Factors
Time Factors
Vincristine--administration & dosage
Wilms Tumor--genetics